STAT+: FDA pauses Regenxbio gene therapy trial again for safety concerns
The FDA put a hold on a Regenxbio gene therapy trial again after new safety concerns emerged.
خواندن متن کامل در استتنیوزبه زبان اصلی، در سایت ناشر باز میشودمتن اصلی (انگلیسی)
STAT+: FDA pauses Regenxbio gene therapy trial again for safety concerns
The FDA put a hold on a Regenxbio gene therapy trial again after new safety concerns emerged.